Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 127573
                    [Title] => Meloxicam is safe, says study
                    [Summary] => PRAGUE — New data presented recently at the 16th European League Against Rheumatism (EULAR) Congress showed that the risk of heart attacks, other cardiac events and renal toxicity in patients taking the nonsteroid anti-inflammatory (NSAID) meloxicam (Mobic) is low. 


The result was similar for patients taking meloxicam and two other commonly prescribed NSAIDs. Moreover, no effects on bleeding time were observed in healthy volunteers with meloxicam at higher than recommended doses.


                    [DatePublished] => 2001-07-23 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

MELOXICAM

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 127573
                    [Title] => Meloxicam is safe, says study
                    [Summary] => PRAGUE — New data presented recently at the 16th European League Against Rheumatism (EULAR) Congress showed that the risk of heart attacks, other cardiac events and renal toxicity in patients taking the nonsteroid anti-inflammatory (NSAID) meloxicam (Mobic) is low. 


The result was similar for patients taking meloxicam and two other commonly prescribed NSAIDs. Moreover, no effects on bleeding time were observed in healthy volunteers with meloxicam at higher than recommended doses.


                    [DatePublished] => 2001-07-23 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

abtest

Meloxicam is safe, says study

July 23, 2001 - 12:00am

PRAGUE — New data presented recently at the 16th European League Against Rheumatism (EULAR) Congress showed that the risk of heart attacks, other cardiac events and renal toxicity in patients taking the nonsteroid...

Science and Environment